Enucleation with unwrapped porous and nonporous orbital implants: A 15-year experience

Ophthalmic Plastic and Reconstructive Surgery

Volumn 21, Issue 5, 2005, Pages 331-336

  Trichopoulos, Nikolaos ^a   Augsburger, James J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYAPATITE; POLY(METHYL METHACRYLATE); POLYETHYLENE;

CONJUNCTIVA; CONTROLLED STUDY; ENUCLEATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; ORBIT IMPLANT; POROSITY; PRIORITY JOURNAL; PROSTHESIS LOOSENING; RETROSPECTIVE STUDY; REVIEW; WOUND DEHISCENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DURAPATITE; EYE ENUCLEATION; FEMALE; FOREIGN-BODY MIGRATION; HUMANS; INFANT; MALE; MIDDLE AGED; ORBITAL IMPLANTS; POLYETHYLENES; POLYMETHYL METHACRYLATE; POROSITY; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; SURGICAL WOUND DEHISCENCE;

EID: 26844540692     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iop.0000175034.88019.a5     Document Type: Review

References (34)

1. Soll DB. The anophthalmic socket. Ophthalmology 1982;89:407-23.
2. Custer PL, Kennedy RH, Woog JJ, et al. Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology. Ophthalmology 2003;110:2054-61.
3. Perry AC. Advances in enucleation. Ophthalmol Clin N Am 1991; 4:173-82.
4. Karesh JW, Dresner SC. High-density porous polyethylene (Medpor) as a successful anophthalmic socket implant. Ophthalmology 1994;101:1688-96.
5. Rubin PA, Popham JK, Bilyk JR, Shore JW. Comparison of fibrovascular ingrowth into hydroxyapatite and porous polyethylene orbital implants. Ophthal Plast Reconstr Surg 1994;10:96-103.
6. Shields CL, Shields JA, Eagle RC, De Potter P. Histopathologic evidence of fibrovascular ingrowth four weeks after implantation of the hydroxyapatite orbital implant. Am J Ophthalmol 1991;111: 363-6.
7. Jordan DR, Anderson RL, Nerad JA, Allen L. A preliminary report on the Universal implant. Arch Ophthalmol 1987;105:1726-31.
8. Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmology 1991;98:370-7.
9. Beard C. Remarks on historical and newer approaches to orbital implants. Adv Ophthal Plast Reconstr Surg 1995;11:89-90.
10. Tyers AG, Collin JR. Baseball orbital implants: a review of 39 patients. Br J Ophthalmol 1985;69:438-42.
11. Fan JT, Robertson DM. Long-term follow-up of the Allen implant (1967-1991). Ophthalmology 1995;102:510-6.
12. Hornblass A, Biesman BS, Eviatar JA. Current techniques of enucleation: a survey of 5439 intraorbital implants and a review of the literature. Ophthal Plast Reconstr Surg 1995;11:77-88.
13. Christmas NJ, Craig GD, Murray TG, et al. Intraorbital implants after enucleation and their complications: a 10-year review. Arch Ophthalmol 1998;116:1199-203.
14. Jordan DR, Klapper SR. Wrapping hydroxyapatite implants. Ophthalmic Surg Lasers 1999;30:403-7.
15. Jordan DR, Gilberg S, Mawn L, et al. The synthetic hydroxyapatite implant: a report on 65 patients. Ophthal Plast Reconstr Surg 1998;14:250-5.
16. Oestreicher JH, Liu E, Berkowitz M. Complications of hydroxyapatite orbital implants: a review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping. Ophthalmology 1997;104:324-9.
17. Gayre GS, DeBacker C, Lipham W, et al. Bovine pericardium as a wrapping for orbital implants. Ophthal Plast Reconstr Surg 2001;17:381-7.
18. Naugle TC, Lee AM, Haik BG, Callahan MA. Wrapping hydroxyapatite orbital implants with posterior auricular muscle complex grafts. Am J Ophthalmol 1999;128:495-501.
19. Kao SC, Chen S. The use of rectus abdominis sheath for wrapping of the hydroxyapatite orbital implants. Ophthalmic Surg Lasers 1999;30:69-71.
20. Long JA, Tann TM, Bearden WH, Callahan MA. Enucleation: is wrapping the implants necessary for optimal motility? Ophthal Plast Reconstr Surg 2003;19:194-7.
21. Jordan DR, Brownstein S, Jolly SS. Abscessed hydroxyapatite orbital implants: a report of two cases. Ophthalmology 1996;103: 1784-7.
22. Anderson RL, Yen MT, Lucci LM, Caruso RT. The quasi-integrated porous polyethylene orbital implant. Ophthal Plast Reconstr Surg 2002;18:50-5.
23. Shields CL, Shields JA, De Potter P, Singh AD. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthalmol Soc 1993;91:177-89.
24. Kaltreider SA, Newman SA. Prevention and management of complications associated with the hydroxyapatite implant. Ophthal Plast Reconstr Surg 1996;12:18-31.
25. Nunery WR, Heinz GW, Bonnin JM, et al. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg 1993;9;96-104.
26. Remulla HD, Rubin PA, Shore JW, et al. Complications of porous spherical orbital implants. Ophthalmology 1995;102:586-93.
27. Li TL, Shen J, Duffy MT. Exposure rates of wrapped and unwrapped orbital implants following enucleation. Ophthal Plast Reconstr Surg 2001;17:431-5.
28. Buettner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol 1992; 113:669-73.
29. Jordan DR, Bawazeer A. Experience with 120 synthetic hydroxyapatite implants (FCI3). Ophthal Plast Reconstr Surg 2001;17: 184-90.
30. McNab A. Hydroxyapatite orbital implants: experience with 100 cases. Aust N Z J Ophthalmol 1995;23:117-23.
31. Christmas NJ, Van Quill K, Murray TG, et al. Evaluation of efficacy and complications: primary pediatric orbital implants after enucleation. Arch Ophthalmol 2000;118:503-6.
32. Lee V, Subak-Sharpe I, Hungerford JL, et al. Exposure of primary orbital implants in postenucleation retinoblastoma patients. Ophthalmology 2000;107:940-5.
33. De Potter P, Shields CL, Shields JA, Singh AD. Use of the hydroxyapatite ocular implant in the pediatric population. Arch Ophthalmol 1994;112:208-12.
34. Karcioglu ZA, Al-Mesfer SA, Mullaney PB. Porous polyethylene orbital implant in patients with retinoblastoma. Ophthalmology 1998;105:1311-6.